Index S&P 500
P/E 40.79
EPS (ttm) 2.54
Insider Own 0.60%
Shs Outstand 251.00M
Perf Week -4.22%
Market Cap 25.20B
Forward P/E 13.10
EPS next Y 7.91
Insider Trans -2.45%
Shs Float 241.78M
Perf Month -7.93%
Income 639.00M
PEG 2.67
EPS next Q 1.96
Inst Own 89.36%
Short Float 3.60%
Perf Quarter -1.97%
Sales 216.15B
P/S 0.12
EPS this Y 25.98%
Inst Trans 0.13%
Short Ratio 3.68
Perf Half Y 10.79%
Book/sh -14.14
P/B -
EPS next Y 8.48%
ROA 1.40%
Short Interest 8.71M
Perf Year 28.90%
Cash/sh 18.88
P/C 5.49
EPS next 5Y 15.27%
ROE -
52W Range 77.56 - 116.04
Perf YTD 2.80%
Dividend Est. 2.03 (1.96%)
P/FCF 7.37
EPS past 5Y 4.23%
ROI 743.02%
52W High -10.70%
Beta 0.71
Dividend TTM 2.00 (1.93%)
Quick Ratio 0.50
Sales past 5Y 8.47%
Gross Margin 3.25%
52W Low 33.60%
ATR (14) 2.12
Dividend Ex-Date Mar 28, 2024
Current Ratio 0.98
EPS Y/Y TTM 155.04%
Oper. Margin 0.97%
RSI (14) 36.76
Volatility 2.02% 1.67%
Employees 48000
Debt/Eq -
Sales Y/Y TTM 11.99%
Profit Margin 0.30%
Recom 2.53
Target Price 115.24
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q 388.09%
Payout 199.53%
Rel Volume 0.38
Prev Close 103.81
Sales Surprise 0.75%
EPS Surprise 13.94%
Sales Q/Q 11.61%
Earnings May 02 BMO
Avg Volume 2.36M
Price 103.62
SMA20 -3.68%
SMA50 -5.27%
SMA200 3.61%
Trades
Volume 784,111
Change -0.18%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated
Leerink Partners
Outperform
$125
Feb-09-24 Upgrade
Argus
Hold → Buy
Jan-03-24 Initiated
Barclays
Overweight
$117
Dec-14-23 Initiated
Wells Fargo
Underweight
$96
Jul-10-23 Downgrade
Evercore ISI
Outperform → In-line
$100
Mar-31-23 Initiated
Citigroup
Neutral
$77
Feb-03-23 Upgrade
Robert W. Baird
Neutral → Outperform
$87 → $94
Nov-04-22 Upgrade
BofA Securities
Underperform → Neutral
$64 → $80
Aug-22-22 Resumed
Morgan Stanley
Overweight
$70 → $76
May-26-22 Downgrade
Barclays
Overweight → Equal Weight
May-18-22 Upgrade
Evercore ISI
In-line → Outperform
$55 → $68
Apr-12-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$74
Apr-01-22 Resumed
Credit Suisse
Neutral
$58
Aug-06-21 Downgrade
Deutsche Bank
Buy → Hold
$62 → $51
Aug-05-21 Downgrade
BofA Securities
Buy → Underperform
$69 → $56
May-10-21 Downgrade
Robert W. Baird
Outperform → Neutral
$66 → $64
Jan-08-21 Upgrade
Wolfe Research
Underperform → Peer Perform
Nov-02-20 Upgrade
Barclays
Equal Weight → Overweight
$57
Sep-25-20 Upgrade
Deutsche Bank
Hold → Buy
$61
Jul-20-20 Upgrade
Guggenheim
Neutral → Buy
Show Previous Ratings
Apr-25-24 01:41PM
01:08PM
10:02AM
Apr-24-24 10:10AM
Apr-23-24 05:50PM
09:00AM
Loading…
09:00AM
Apr-22-24 08:01PM
04:40PM
04:30PM
04:22PM
(Investor's Business Daily)
04:16PM
03:56PM
03:13PM
02:03PM
(The Wall Street Journal)
01:55PM
01:39PM
Loading…
01:39PM
01:34PM
12:11PM
12:07PM
10:12AM
09:55AM
07:29AM
07:19AM
06:54AM
06:45AM
Apr-15-24 05:50PM
Apr-12-24 09:00AM
Apr-09-24 09:23AM
Apr-08-24 05:50PM
09:40AM
12:10PM
Loading…
Apr-04-24 12:10PM
11:59AM
Apr-02-24 08:00AM
Mar-28-24 10:03AM
Mar-27-24 07:10AM
Mar-26-24 08:02AM
06:45AM
Mar-25-24 09:40AM
Mar-22-24 09:40AM
Mar-21-24 12:45PM
Mar-20-24 09:50AM
Mar-15-24 08:00AM
Mar-14-24 10:33AM
Mar-11-24 09:56AM
Mar-07-24 09:40AM
Mar-06-24 09:40AM
Mar-04-24 05:00AM
Feb-29-24 09:15AM
06:00AM
Feb-28-24 04:15PM
12:45PM
Feb-22-24 09:50AM
Feb-19-24 09:40AM
Feb-15-24 01:26PM
Feb-14-24 04:48PM
(The Wall Street Journal)
03:33PM
(Investor's Business Daily)
Feb-12-24 12:45PM
Feb-08-24 06:09PM
Feb-06-24 04:35PM
07:30AM
Feb-05-24 02:27AM
Feb-02-24 09:48AM
12:06AM
Feb-01-24 10:46PM
(Thomson Reuters StreetEvents)
01:08PM
01:04PM
12:19PM
11:13AM
10:39AM
09:53AM
09:40AM
09:30AM
09:15AM
07:55AM
07:15AM
06:56AM
(Associated Press Finance)
06:45AM
04:30AM
Jan-31-24 12:24PM
09:40AM
07:10AM
06:51AM
06:45AM
Jan-30-24 07:46AM
Jan-29-24 09:16AM
Jan-26-24 12:45PM
Jan-25-24 10:00AM
Jan-16-24 09:40AM
09:40AM
Jan-15-24 09:40AM
Jan-10-24 09:13AM
Jan-09-24 07:03AM
06:45AM
Jan-03-24 01:59PM
(The Wall Street Journal)
Jan-02-24 06:55AM
Jan-01-24 03:51PM
Dec-28-23 05:08AM
Dec-24-23 07:31PM
Dec-15-23 02:46PM
Dec-14-23 12:55PM
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
WEITZMAN DEBORAH CEO, Pharmaceutical Segment Nov 27 '23 Option Exercise 74.10 27,642 2,048,356 71,844 Nov 29 09:14 AM WEITZMAN DEBORAH CEO, Pharmaceutical Segment Nov 27 '23 Sale 106.31 36,642 3,895,411 35,202 Nov 29 09:14 AM WEITZMAN DEBORAH CEO, Pharmaceutical Segment Aug 28 '23 Option Exercise 71.43 6,712 479,438 50,914 Aug 29 04:21 PM WEITZMAN DEBORAH CEO, Pharmaceutical Segment Aug 28 '23 Sale 89.81 6,712 602,805 44,202 Aug 29 04:21 PM Scherer Mary C. Chief Accounting Officer Aug 18 '23 Option Exercise 75.36 11,460 863,646 31,344 Aug 21 04:16 PM Scherer Mary C. Chief Accounting Officer Aug 18 '23 Sale 86.27 20,695 1,785,358 10,649 Aug 21 04:16 PM Snow Ola M Chief Human Resources Officer Aug 17 '23 Option Exercise 71.43 3,907 279,077 52,086 Aug 17 07:47 PM Mason Stephen M CEO, Medical Segment Aug 17 '23 Sale 87.32 37,500 3,274,642 37,355 Aug 17 07:52 PM Snow Ola M Chief Human Resources Officer Aug 17 '23 Sale 87.41 26,324 2,301,053 25,762 Aug 17 07:47 PM Mayer Jessica L Chief Legal/Compliance Officer Aug 17 '23 Sale 87.68 10,668 935,370 84,865 Aug 17 07:57 PM Greene Michelle D. Chief Information Officer Aug 17 '23 Sale 86.79 2,000 173,580 20,814 Aug 17 07:49 PM Mayer Jessica L Chief Legal/Compliance Officer Aug 16 '23 Option Exercise 77.34 2,115 163,568 125,678 Aug 17 07:57 PM Mayer Jessica L Chief Legal/Compliance Officer Aug 16 '23 Sale 90.84 30,145 2,738,372 95,533 Aug 17 07:57 PM Mayer Jessica L Chief Legal/Compliance Officer Aug 07 '23 Option Exercise 51.49 813 41,861 130,917 Aug 08 07:45 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite